Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
1.350
+0.030 (2.27%)
At close: Apr 15, 2025, 4:00 PM
1.370
+0.020 (1.48%)
After-hours: Apr 15, 2025, 5:06 PM EDT
Editas Medicine Market Cap
Editas Medicine has a market cap or net worth of $112.02 million as of April 15, 2025. Its market cap has decreased by -81.55% in one year.
Market Cap
112.02M
Enterprise Value
-122.86M
1-Year Change
-81.55%
Ranking
Category
Stock Price
$1.35
Market Cap Chart
Since February 3, 2016, Editas Medicine's market cap has decreased from $649.70M to $112.02M, a decrease of -82.76%. That is a compound annual growth rate of -17.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2025 | 109.50M | 4.48% |
| Dec 31, 2024 | 104.80M | -87.33% |
| Dec 29, 2023 | 827.40M | 35.66% |
| Dec 30, 2022 | 609.90M | -66.42% |
| Dec 31, 2021 | 1.82B | -58.45% |
| Dec 31, 2020 | 4.37B | 187.69% |
| Dec 31, 2019 | 1.52B | 39.66% |
| Dec 31, 2018 | 1.09B | -15.40% |
| Dec 29, 2017 | 1.29B | 122.48% |
| Dec 30, 2016 | 577.90M | -11.05% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 674.19B |
| UnitedHealth Group | 535.41B |
| Johnson & Johnson | 368.85B |
| AbbVie | 315.06B |
| Novo Nordisk | 283.15B |
| Abbott Laboratories | 221.77B |
| AstraZeneca | 202.51B |
| Novartis AG | 200.23B |